{"@context":"https://schema.org","@type":"Corporation","name":"VIVIMED LABS LIMITED","alternateName":"VIVIMEDLAB","tickerSymbol":"VIVIMEDLAB","identifier":"VIVIMEDLAB","description":"VIVIMED LABS LIMITED (VIVIMEDLAB) financials: Market Cap ₹54.6Cr., Price ₹6.58, ROE %. Mar 2026: sales ₹8 Cr, net profit ₹-142 Cr. Quarterly results, P&L, cash…","url":"https://fincrux.org/companies/VIVIMEDLAB","sameAs":["https://fincrux.org/companies/VIVIMEDLAB"],"dateModified":"2026-10-17T09:40:01.734546","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹54.6Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹6.58"},{"@type":"PropertyValue","name":"ROE","value":"%"},{"@type":"PropertyValue","name":"ROCE","value":"-47.3%"},{"@type":"PropertyValue","name":"Book Value","value":"₹-13.5"},{"@type":"PropertyValue","name":"Dividend Yield","value":"0.00%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹29.4/4.75"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/VIVIMEDLAB#webpage","name":"VIVIMED LABS LIMITED (VIVIMEDLAB) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/VIVIMEDLAB","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/VIVIMEDLAB"}}